
As of February 9, 2019, regulations resulting from the so-called Falsified Medicines Directive and delegated regulations regarding the verification of the authenticity of medicinal products come into force. The regulation imposes an obligation on marketing authorization holders to place two-dimensional codes on medicinal products, in which a so-called unique identifier will be encoded. The new regulations mean not only an end to drug counterfeiting but will also force pharmacies and hospitals to purchase necessary equipment, including scanners and software.
The implementation of legal requirements will rest on all participants in the pharmaceutical supply chain to the extent specified by the provisions of the regulation. The marketing authorization holder will feed the European database with information on batches of medicines released from February 9, distributors will be required to perform random checks of the authenticity of medicines, and pharmacies will be required to verify the authenticity of medicines before dispensing them to patients based on the national medicine verification system. The new requirements apply to prescription medicinal products. The method of labeling over-the-counter medicines will not change.
In accordance with legal conditions in Poland, all products authorized for sale in Poland are labeled using the EAN-13 code, which presents the Global Trade Item Number (GTIN for short), in accordance with the global GS1 standard. From 2019, this number will be an element of the unique identifier and will serve as a product code for prescription medicinal products. The difference between the current method of labeling products and the new approach will consist of:
– changing the barcode symbology from linear to two-dimensional,
– adding an individual serial number to the packaging,
– presenting all elements in the form of a barcode.
– The market for counterfeit drugs purchased in Poland is estimated at 65 million euros. Counterfeiting brings large profits – on a global scale, it is estimated at 90 billion dollars. The WHO estimates that 120,000 school-age children in Africa die of malaria because they receive a drug for this disease without an active substance. About 98 percent of online pharmacies are illegal. The goal of the Falsified Medicines Directive is to seal the legal distribution chain. GS1 standards are an extremely important element of this solution – comments Dr. Anna Gawrońska, expert on GS1 standards in healthcare.







